National Heart, Lung, and Blood Institute; Notice of Closed Meetings, 37413-37414 [05-12800]
Download as PDF
<![CDATA[
37413
Federal Register / Vol. 70, No. 124 / Wednesday, June 29, 2005 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Comment Request
Proposed projects: Title:
Developmental Disabilities Protection
and Advocacy Program Performance
Report.
OMB No.: 0980–0160.
Description: This information
collection is required by federal statute.
Each State Protection and Advocacy
System must prepare and submit a
Program Performance Report for the
preceding fiscal year of activities and
accomplishments and of conditions in
the State. The information in the
Annual Report will be aggregated into a
national profile of Protection and
Advocacy Systems. It will also provide
ADD with an overview of program
trends and achievements and will
enable ADD to respond to
administration and congressional
requests for specific information on
program activities. This information
will also be used to submit a Biennial
Report to Congress as well as to comply
with requirements in the Government
Performance and Results Act of 1993.
Respondents: Protection & Advocacy
Agencies.
Annual Burden Estimates
Instrument
Number of
respondents
Number of
responses per
respondent
Average
burden hours
per response
Total burden
hours
Developmental disabilities Protection and Advocacy Program Performance
Report ...........................................................................................................
57
1
44
2,508
Estimated Total Annual Burden
Hours: 2,508.
In compliance with the requirements
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Administration,
Office of Information Services, 370
L’Enfant Promenade, SW., Washington,
DC 20447, Attn: ACF Reports Clearance
Officer. E-mail address:
grjohnson@acf.hhs.gov. All requests
should be identified by the title of the
information collection.
The Department specifically requests
comments on: (a) Whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information; (c) the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Consideration will be given
to comments and suggestions submitted
within 60 days of this publication.
Dated: June 23, 2005.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 05–12823 Filed 6–28–05; 8:45 am]
BILLING CODE 4184–01–M
VerDate jul<14>2003
17:40 Jun 28, 2005
Jkt 205001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung and Blood
Institute, Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in section
552(b)(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel
Molecular & Cellular Mechanisms in
Transfusion Medicine.
Date: July 1, 2005.
Time: 10 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Room 7214, Bethesda, MD
20892, (Telephone Conference Call).
Contact Person: Valerie L. Prenger, PhD,
Scientific Review Administrator, Division of
Extramural Affairs, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7214, Bethesda, MD 20892–7924, (301) 435–
0270, prengerv@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
PO 00000
Frm 00093
Fmt 4703
Sfmt 4703
and Resources Research, National Institutes
of Health, HHS)
Dated: June 21, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–12787 Filed 6–28–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Resource-Related Research Project
Applications (R24s).
Date: July 12, 2005.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Heart, Lung, and Blood
Institute, Rockledge, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference
Call).
E:\FR\FM\29JNN1.SGM
29JNN1
37414
Federal Register / Vol. 70, No. 124 / Wednesday, June 29, 2005 / Notices
Contact Person: Ying Ying Li-Smerin,
Ph.D., M.D., Scientific Review Administrator,
Division of Extramural Affairs, Review
Branch, National Heart, Lung, and Blood
Institute, NIH, 6701 Rockledge Drive, Room
7184, Bethesda, MD 20814, (301) 435–0275,
lismerin@nhlbi.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Review of Research Scientist Development
(K02s) and Clinical Investigator (K08s)
Applications.
Date: August 11–12, 2005.
Time: 1:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: St. Gregory Hotel, 2033 M Street,
NW., Washington, DC 20036.
Contact Person: Zoe Huang, M.D., Health
Scientist Administrator, Review Branch,
Room 7190, Division of Extramural Affairs,
National Heart, Lung, and Blood Institute,
6701 Rockledge Drive, Room 7190, Bethesda,
MD 20892–7924, (301) 435–0314,
huangz@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Special Emphasis Panel, Persistent
Symptoms After ASI, Effect of Subsequent
Deliveries and Biofeedback.
Date: July 19, 2005.
Time: 10 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: NICHD, 6100 Executive Blvd., 5B01,
Rockville, MD 20892, (telephone conference
call).
Contact Person: Jon M. Ranhand, PhD,
Scientist Review Administrator, Division of
Scientific Review, National Institute of Child
Health, and Human Development, NIH, 6100
Executive Boulevard, Room 5B01, Bethesda,
MD 20892, (301) 435–6884,
ranhandj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Scientific Review, National Institute of Child
Health and Human Development, NIH, 6100
Executive Boulevard, Room 5B01, Bethesda,
MD 20892, (301) 435–6884,
ranhandj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: June 21, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–12789 Filed 6–28–05; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–M
Dated: June 22, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–12800 Filed 6–28–05; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–M
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Child Health and
Human Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
VerDate jul<14>2003
19:10 Jun 28, 2005
Jkt 205001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Child Health and
Human Development; Notice of Closed
Meeting
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel, Genomic
Fingerprint of PGF2alpha and LH Actions on
the Luteal Transcriptome in Primates.
Date: July 21, 2005.
Time: 10 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Room 5B01, Rockville,
MD 20852 (telephone conference call).
Contact Person: Jon M. Ranhand, PhD,
Scientific Review Administrator, Division of
PO 00000
Frm 00094
Fmt 4703
Sfmt 4703
Dated: June 21, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–12790 Filed 6–28–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Clinical Investigator
Application Review.
Date: July 22, 2005.
Time: 3 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Lakshmanan Sankaran,
PhD, Scientific Review Administrator,
Review Branch, DEA, NIDDK, National
Institutes of Health, Room 777, 6707
Democracy Boulevard, Bethesda, MD 20892–
5452, (301) 594–7799, Is38oz@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS).
E:\FR\FM\29JNN1.SGM
29JNN1
]]>Agencies
[Federal Register Volume 70, Number 124 (Wednesday, June 29, 2005)]
[Notices]
[Pages 37413-37414]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-12800]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel, Resource-Related Research Project
Applications (R24s).
Date: July 12, 2005.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant applications.
Place: National Heart, Lung, and Blood Institute, Rockledge,
6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference
Call).
[[Page 37414]]
Contact Person: Ying Ying Li-Smerin, Ph.D., M.D., Scientific
Review Administrator, Division of Extramural Affairs, Review Branch,
National Heart, Lung, and Blood Institute, NIH, 6701 Rockledge
Drive, Room 7184, Bethesda, MD 20814, (301) 435-0275,
lismerin@nhlbi.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel, Review of Research Scientist Development
(K02s) and Clinical Investigator (K08s) Applications.
Date: August 11-12, 2005.
Time: 1:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: St. Gregory Hotel, 2033 M Street, NW., Washington, DC
20036.
Contact Person: Zoe Huang, M.D., Health Scientist Administrator,
Review Branch, Room 7190, Division of Extramural Affairs, National
Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7190,
Bethesda, MD 20892-7924, (301) 435-0314, huangz@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: June 22, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-12800 Filed 6-28-05; 8:45 am]
BILLING CODE 4140-01-M
